Bioequivalence Study of Fixed Dose Versus Single Entities of Dolutegravir and Lamivudine
Clinical trial NCT03078556 · COMPLETED
Trial details
- NCT number
- NCT03078556
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-27
- Primary completion
- 2017-08-18
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.